Total Funding
71
70
Total FundingDebt Financing raised
Growth Score 71 in past quarter
-4 pts
Heat Score 70 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
24333
Nuclein is a biotechnology company that develops the polymerase chain reaction test device for infectious diseases.
Jeffrey Stukuls: CFOPast Role: Steelcase, Internal Financial Accounting and Other Matters- Alan Blake: Chief Executive Officer
About the Company
Nuclein is a biotechnology company that develops the Hand-Held Polymerase Chain Reaction test device for infectious diseases. The test device is a disposable, all-in-one, self-testing device for infectious disease diagnosis that does not require any technical expertise and provides battery-powered, sample-to-answer results in under one hour,
without the need to mail in a sample.